Tech Company Financing Transactions

Anchor Therapeutics Funding Round

On 6/30/2009, Anchor Therapeutics received $10 million in funding from HealthCare Ventures, Novartis Venture Fund and TVM Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

67 Rogers St. Bldg 600 - 6201
Cambridge, MA 02142
USA

Phone

(617) 715-1999

Website

www.anchortx.com

Email Address

[email protected]

Overview

Anchor Therapeutics develops pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease, and pain.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Scientific Officer

Stephen Hunt

        

President

Thomas McMurry

        

Browse more venture capital transactions:

Prev: 6/30/2009: Biofisica venture capital transaction
Next: 6/30/2009: Cebix venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary